Qiagen NV's revenue for the
three
months ended in Dec. 2023 was $509 Mil.
Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $1,965 Mil.
Qiagen NV's Revenue per Share for the
three
months ended in Dec. 2023 was $2.28.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $8.81.
Warning Sign:
Qiagen NV revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Qiagen NV was -8.40% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 2.20% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 7.60% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 6.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Qiagen NV's highest 3-Year average Revenue per Share Growth Rate was 36.20% per year. The lowest was -0.30% per year. And the median was 9.25% per year.
Qiagen NV Revenue Historical Data
The historical data trend for Qiagen NV's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Qiagen NV's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qiagen NV's Revenue Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Qiagen NV's Revenue distribution charts can be found below:
* The bar in red indicates where Qiagen NV's Revenue falls into.
Qiagen NV Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,965 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qiagen NV (NYSE:QGEN) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Qiagen NV Revenue Related Terms
Thank you for viewing the detailed overview of Qiagen NV's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (over 45% of 2022 sales), followed by EMEA (nearly 35%), and Asia-Pacific (nearly 20%).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
QGEN has been successfully added to your 